Elevated levels of soluble TNF receptors in bronchoalveolar lavage fluid in extrinsic allergic alveolitis

Clinical and Experimental Allergy

Volumn 29, Issue 9, 1999, Pages 1209-1213

  Dai, H ^a   Guzman, J ^b   Bauer, P C ^a   Costabel, U ^a,c  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c RUHRLANDKLINIK   (Germany)

Author keywords

Bronchoalveolar lavage; Extrinsic allergic alveolitis; Soluble TNF receptor

Indexed keywords

TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ALLERGIC PNEUMONITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG LAVAGE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T LYMPHOCYTE;

AGED; ALVEOLITIS, EXTRINSIC ALLERGIC; BRONCHOALVEOLAR LAVAGE FLUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 0032866869     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1999.00632.x     Document Type: Article

References (35)

1. Beutler B, Cerami A. The biology of cachectin/TNF: a primary mediator of the host response. Annu Rev Immunol 1989; 7:625-55.
2. Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994; 76:959-62.
3. Tartaglia LA, Goeddel DV. Trends. Two TNF receptors. Immunol Today 1992; 13:151-3.
4. Brockhaus M, Schoenfeld HJ. Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 1990; 87:3127-31.
5. Santee SM, Owen-Schaub LB. Human tumor necrosis factor receptor p75/80 (CD120b) gene structure and promoter characterization. J Biol Chem 1996; 271:21151-9.
6. Agostini C, Zambello R, Sancetta R et al. Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease. Am J Respir Crit Care Med 1996; 153:1359-67.
7. Ware CF, Crowe PD, Vanarsdale TL et al. Tumor necrosis factor (TNF) receptor expression in T lymphocytes: Differential regulation of the type I TNF receptor during activation of resting and effector T cells. J Immmunol 1991; 147:4229-38.
8. Imamura K, Spriggs D, Kufe D. Expression of tumor necrosis factor receptors on human monocytes and internalization of receptor bound ligand. J Immunol 1987; 139:2989-92.
9. Heilig V, Mapara M, Brockhaus M, Krauth K, Dörken B. Two types of TNF receptors are expressed on human normal and malignant B lymphocytes. Clin Immunol Immunopath 1991; 61:260-7.
10. Gehr G, Gentz R, Brockhaus M, Loetscher H, Lesslauer W. Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation. J Immunol 1992; 149:911-7.
11. Naume B, Shalaby R, Lesslauer W, Espevik T. Involvement of the 55- and 75-kDa tumor necrosis factor receptors in the generation of lymphokine-activated killer cell activity and proliferation of natural killer cells. J lmmunol 1991; 146:3045-8.
12. Williams LM, Gibbons DL, Gearing A et al. Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF processing in RA synovial membrane cell cultures. J Clin Invest 1996; 97:2833-41.
13. Williams MA, Kouroumoussis J, Syndercombe-Court D et al. Administration of recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy regulates the expression and secretion of monocyte tumor necrosis factor (TNF) and TNF receptors p55 and p75. Blood 1995; 86:4234-42.
14. Leeuwenberg JFM, Dentener MA, Buurman WA. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes: role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein. J Immunol 1994; 152:5070-6.
15. Hart PH, Hunt EK, Bonder CF et al. Regulation of surface and soluble TNF receptor expression on human monocytes and synovial fluid macrophages by IL-4 and IL-10. J Immunol 1996; 157:3672-80.
16. Leeuwenberg JFM, Jeunhomme TMAA, Buurman WA. Slow release of soluble TNF receptors by monocytes in vitro. J Immunol 1994; 152:4036-43.
17. Van Zee KJ, Kohno T, Fischer E et al. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor in vitro and in vivo. Proc Natl Acad Sci USA 1992; 89:4845-9.
18. Lantz M, Gullberg U, Nilsson E, Olsson I. Characterization in vitro of a human tumor necrosis factor-binding protein: a soluble form of a tumor necrosis factor receptor. J Clin Invest 1990; 86:1396-402.
19. Evans TJ, Moyes D, Carpenter A et al. Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of Gram-negative sepsis. J Exp Med 1994; 180:2173-9.
20. Spuler S, Ypusry T, Scheller A et al. Multiple sclerosis: prospective analysis of TNF-α and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activity. J Neuroimmunol 1996; 66:57-64.
21. Nakayama T, Hashimoto S, Amemiya E, Horie T. Elevation of plasma-soluble tumor necrosis factor receptors (TNF-R) in sarcoidosis. Clin Exp Immunol 1996; 104:318-24.
22. Heilig B, Wermann M, Gallati H et al. Elevated TNF receptor plasma concentrations in patients with rheumatoid arthritis. Clin Invest 1992; 70:22-7.
23. Cope AP, Aderka D, Doherty M et al. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthr Rheum 1992; 35:1160-8.
24. Hino T, Nakamura H, Shibata Y et al. Elevated levels of type II soluble tumor necrosis factor receptors in the bronchoalveolar lavage fluids of patients with sarcoidosis. Lung 1997; 175:187-93.
25. Olsson I, Lants M, Nilsson E et al. Isolation and characterization of a tumor necrosis factor-binding protein from urine. Eur J Haematol 1989; 42:270-5.
26. Peetre C, Thysell T, Grubb A, Olsson I. A tumor necrosis factor-binding protein is present in human biological fluids. Eur J Haematol 1988; 41:414-9.
27. Denis M, Cormier Y, Fournier M, Tardif J, Laviolette M. Tumor necrosis factor plays an essential role in determining hypersensitivity pneumonitis in a mouse model. Am J Respir Cell Mol Biol 1991; 5:477-83.
28. Denis M, Bedard M, Laviolette M, Cormier Y. A study of monokine release and natural killer activity in the bronchoalveolar lavage of subjects with farmer's lung. Am Rev Respir Dis 1993; 147:934-9.
29. Costabel U, Bross KJ, Rühle KH, Löhr GW, Matthys H. Ia-like antigens on T-cell and their subpopulations in pulmonary sarcoidosis and in hypersensitivity pneumonitis. Am Rev Respir Dis 1985; 131:337-42.
30. Reynolds HY. Hypersensitivity pneumonitis: correlation of cellular and immunologie changes with clinical phases of disease. Lung 1988; 166:189-208.
31. Trentin L, Migone N, Zambello R. Mechanisms accounting for lymphocytic alveolitis in hypersensitivity pneumonitis. J Immunol 1990; 145:2147-54.
32. Jäättelä M. Biology of disease. Biologic activities and mechanisms of action of tumor necrosis factor-̈/cachectin. Lab Invest 1991; 64:724-42.
33. Keller J. Cytokines of the lung. Am Rev Respir Dis 1990; 141:765-88.
34. Denis M. Proinflammatory cytokines in Hypersensitivity pneumonitis. Am J Respir Crit Care Med 1995; 151:164-9.
35. Sugiyama Y, Kasahara T, Mukaida N et al. Chemokines in bronchoalveolar lavage fluid in summer-type hypersensitivity pneumonitis. Eur Respir J 1995; 8:1084-90.